Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
An oral antiviral drug from Korea may be a problem solver for COVID-19 2021-05-13 16:37
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer 2021-05-11 04:01
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases 2021-05-10 08:13
China Jo-Jo Drugstores Hosts Reception for Provincial Government Officials 2021-05-06 20:30
Carmine Therapeutics appoints Don Haut as CEO 2021-05-05 21:00
Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products 2021-05-04 21:08
Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor 2021-05-03 09:30
I-Mab Announces Upcoming Participation at May Conferences 2021-04-29 20:00
I-Mab Filed 2020 Annual Report on Form 20-F 2021-04-28 20:00
Samsung Biologics Reports First Quarter 2021 Financial Results 2021-04-28 16:37
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services 2021-04-28 14:00
Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals 2021-04-27 14:00
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis 2021-04-26 19:00
Vaccines: More cooperation, less speculation 2021-04-22 21:00
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life." 2021-04-21 19:00
China Biologic Announces Completion of Going Private Transaction 2021-04-21 04:30
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005 2021-04-20 20:54
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration 2021-04-20 08:30
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port 2021-04-19 20:30
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection 2021-04-19 20:15
1 105 106 107 108 109 165